SEC Form 4 · accession 0001078782-19-000133
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Habib Skaff
Director
Period of report
Feb 11, 2019
Accepted (ET)
Feb 13, 2019 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.25 | Feb 11, 2019 | A | 15,000 | A | Feb 11, 2020 | Feb 11, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1A total of 15,000 Options were granted on February 11, 2019 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.